From: Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression
Ā | OS | PFS |
---|---|---|
HR (95% CI) P-value | HR (95% CI) P-value | |
Clinical parameters | ||
Age, (ā¤ 65 vā>āĀ 65) | 1.50 (0.84ā2.67) Pā=ā0.170 | 1.39 (0.81ā2.39) Pā=ā0.230 |
Sex, (Male v Female) | 1.18 (0.68ā2.06) Pā=ā0.559 | 1.061 (0.66ā1.81) Pā=ā0.829 |
TNM stage, (Iā+āII vs. IIIā+āIV) | 2.76 (1.45ā5.24) Pā=ā0.002 | 2.10 (1.18ā3.73) Pā=ā0.012 |
Risk factors | ||
āGall stone (no v yes) | 1.58 (0.89ā2.81) Pā=ā0.117 | 1.47 (0.85ā2.54) Pā=ā0.166 |
āDiabetes (no v yes) | 1.27 (0.66ā2.45) Pā=ā0.467 | 1.15 (0.64ā2.05) Pā=ā0.640 |
āHypertension (no v yes) | 1.40 (0.77ā2.52) Pā=ā0.270 | 1.50 (0.86ā2.63) Pā=ā0.156 |
āCholecystitis (no v yes) | 1.34 (0.74ā2.41) Pā=ā0.335 | 1.34 (0.77ā2.35) Pā=ā0.304 |
Jaundice (no v yes) | 2.82 (1.49ā5.33) Pā=ā0.001 | 2.58 (1.35ā4.92) Pā=ā0.004 |
Completed resection (no v yes) | 0.38 (0.21ā0.68) Pā=ā0.001 | 0.40 (0.22ā0.72) Pā=ā0.002 |
CEA (>ā 5Ā Ī¼g/L) | 1.97 (1.08ā3.60) Pā=ā0.028 | 1.61 (0.90ā2.89) Pā=ā0.110 |
CA19ā9 (>ā 34Ā U/mL) | 2.77 (1.52ā5.06) Pā=ā0.001 | 2.28 (1.28ā4.04) Pā=ā0.005 |
Liver dysfunction | ||
āALT (>ā 40Ā U/L) | 2.13 (1.15ā3.95) Pā=ā0.016 | 2.04 (1.10ā3.79) Pā=ā0.023 |
āAST (>ā 35Ā U/L) | 1.63 (0.91ā2.91) Pā=ā0.099 | 1.34 (0.79ā2.42) Pā=ā0.264 |
āTBil (>ā 22.2Ā Ī¼mol/L) | 1.625 (0.91ā2,90) Pā=ā0.101 | 1.38 (0.79ā2.44) Pā=ā0.261 |
āDBil (>ā 6.8Ā Ī¼mol/L) | 2.71 (1.50ā4.91) Pā=ā0.001 | 2.45 (1.35ā4.47) Pā=ā0.003 |
āGGT (>ā 45Ā U/L) | 2.34 (1.31ā4.17) Pā=ā0.004 | 2.055 (1.17ā3.61) Pā=ā0.013 |
āALP (>ā 135Ā U/L) | 1.99 (1.12ā3.56) Pā=ā0.020 | 1.75 (0.99ā3.08) Pā=ā0.055 |
Pathological features | ||
Differentiation (moderate vs. poor) | 1.95 (1.10ā3.46) Pā=ā0.023 | 1.57 (0.92ā2.68) Pā=ā0.100 |
Mean tumor size (ā¤ 3.0 vā>ā3.0Ā cm) | 1.07 (0.61ā1.88) Pā=ā0.816 | 1.02 (0.60ā1.72) Pā=ā0.955 |
Immunohistochemistry | ||
āCD133+ in TCs | 1.09 (0.62ā1.91) Pā=ā0.776 | 0.99 (0.58ā1.71) Pā=ā0.994 |
āCD8+ TILs (CD8low vs. CD8high) | 0.49 (0.28ā0.86) Pā=ā0.014 | 0.54 (0.31ā0.93) Pā=ā0.026 |
āPD-1+ in TILs | 1.14 (0.66ā1.98) Pā=ā0.636 | 1.26 (0.74ā2.13) Pā=ā0.398 |
āPD-L1+ in TCs | 1.92 (0.95ā3.88) Pā=ā0.067 | 1.87 (0.95ā3.68) Pā=ā0.071 |
āPD-L1ā vs. PD-L1+ | 1.86 (1.04ā3.33) Pā=ā0.038 | 1.60 (0.93ā2.75) Pā=ā0.088 |
āPD-L2- vs. PD-L2+ | 1.52 (0.82ā2.80) Pā=ā0.185 | 1.40 (0.80ā2.46) Pā=ā0.242 |
Classification based on PD-L1 expression and CD8+ TILs | ||
āOverall | NA; Pā=ā0.003 | NA; Pā=ā0.018 |
āI vs. II | 3.14 (1.11ā8.85) Pā=ā0.031 | 2.40 (1.03ā5.59) Pā=ā0.042 |
āI vs. III | 3.36 (1.21ā9.30) Pā=ā0.020 | 2.75 (1.16ā6.51) Pā=ā0.021 |
āI vs. IV | 7.38 (2.49ā21.89) <ā0.001 | 4.81 (1.81ā12.78) Pā=ā0.002 |